Press "esc" to clear
Go to Advanced Search

Showing results

110 of 216
  • Embargo expired:
    18-Apr-2018 5:00 PM EDT

Article ID: 693120

Pioneering Gene Therapy by UCSF Benioff Children’s Hospital Oakland Researchers Demonstrates Therapy Can Eliminate Life-Long Need for Transfusions in Patients with Incurable Blood Disorder

UCSF Benioff Children's Hospital Oakland

Interim results of clinical trials by investigators at UCSF Benioff Children’s Hospital Oakland and Ann and Robert H. Lurie Children’s Hospital of Chicago reveal that a majority of the 22 patients in two Phase 1/2 studies followed for two years or longer remained free from transfusions. The results of the trials “Gene Therapy in Patients with Transfusion-Dependentβ-Thalassemia,” are published today in the New England Journal of Medicine (NEJM). The results are from two separate, two-year clinical studies using LentiGlobin® gene therapy to stop or reduce chronic blood transfusions in patients with transfusion-dependent β-thalassemia (TDT).

Released:
18-Apr-2018 6:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Opioidtexts-700x467-1.jpg

Article ID: 692977

Text Messaging Tool May Help Fight Opioid Epidemic

Washington University in St. Louis

Washington University School of Medicine in St. Louis and Epharmix, a digital health company, have created a new automated text messaging service that may curb opioid abuse and prevent relapse. Patients receive text messages to gauge if they’re feeling OK or struggling with potential relapse. Patients also can activate a panic button to request immediate help.

Released:
17-Apr-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
hans-hammers-thumb.jpg

Article ID: 692952

FDA Approves New Standard of Care for Kidney Cancer

UT Southwestern Medical Center

The U.S. Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer.

Released:
17-Apr-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    16-Apr-2018 9:30 AM EDT

Article ID: 692470

Combination of Pembrolizumab and Chemotherapy Doubles Survival in Patients with Metastatic Lung Cancer

NYU Langone Health

The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking genetic changes in the EGFR or ALK genes, when compared to chemotherapy alone, according to an international, Phase III clinical trial.

Released:
10-Apr-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
cancer_cells.jpg
  • Embargo expired:
    16-Apr-2018 9:30 AM EDT

Article ID: 692706

Drug Reduces Size of Some Lung Cancer Tumors, Relapse Rate After Surgery

Johns Hopkins Medicine

A drug given to early stage lung cancer patients before they undergo surgery showed major tumor responses in the removed tumor and an increase in anti-tumor T-cells that remained after the tumor was removed, which resulted in fewer relapse cases in the patients.

Released:
12-Apr-2018 1:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    13-Apr-2018 1:30 PM EDT

Article ID: 692619

Mount Sinai Research on Omega-3 Fatty Acid Supplementation for Dry Eye

Mount Sinai Health System

Results show supplement is no better than placebo in relieving signs and symptoms of disease.

Released:
11-Apr-2018 3:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    13-Apr-2018 1:30 PM EDT

Article ID: 692637

New Study Finds Omega-3 Fatty Acid Supplements Ineffective in Treating Dry Eye Disease

Perelman School of Medicine at the University of Pennsylvania

Findings from a new randomized clinical trial, now show that contrary to a long held belief in the ophthalmic community, omega-3 supplements are no more effective than placebo at alleviating dry eye symptoms.

Released:
11-Apr-2018 4:50 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
capsulescroppedwithattribution.jpg
  • Embargo expired:
    13-Apr-2018 1:30 PM EDT

Article ID: 692797

Omega-3s From Fish Oil Supplements No Better Than Placebo for Dry Eye

NIH, National Eye Institute (NEI)

Omega-3 fatty acid supplements taken orally proved no better than placebo at relieving symptoms or signs of dry eye, according to the findings of a well-controlled trial funded by the National Eye Institute (NEI), part of the National Institutes of Health.

Released:
13-Apr-2018 12:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
DNA_Strands_blue_iStock-92883894TW.jpg

Article ID: 692272

Don't Forget The "epi" In Genetics Research, Johns Hopkins Scientist Says

Johns Hopkins Medicine

In a review article published April 5 in the New England Journal of Medicine, scientist Andrew Feinberg, M.D., calls for more integration between two fields of DNA-based research: genetics and epigenetics.

Released:
5-Apr-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Armitage_James_2016.jpg
  • Embargo expired:
    28-Mar-2018 5:00 PM EDT

Article ID: 691842

Two Leading Oncologists Co-Author Paper on Nuclear Terrorism

University of Nebraska Medical Center (UNMC)

Special report details serious concerns that medical community would be able to do much, if anything, to assist people in event of major nuclear event. Prevention is best option as well as carefully conceived, long-term plan within the public education system to provide lessons on radiation biology

Released:
28-Mar-2018 5:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 216





Chat now!